Leif Bertilsson - Concepedia

Author

Leif Bertilsson

Also Known As

L BERTILSSON, L Bertilsson, L. BERTILSSON, L. Bertilsson, L. Bertilsson, LEIF BERTILSSON, Leif BERTILSSON, Leif Bertilsson, Leif Bertilsson (431119), Leif. Bertilsson

341

Publications

22.7K

Citations

H-Index

166

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Integrated Cardio Metabolic Centre Universidad de Extremadura Stockholm South General Hospital

About

Leif Bertilsson is an author at Karolinska Institutet specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	52	104	7.6K
2	Health Sciences	10	10	435
3	Natural Sciences	8	8	621
4	Arts	2	2	226
5	Public Health	2	2	124

Leif Bertilsson

234

Publications

19.4K

Citations

H-Index

Page 1

	Year	Citations
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants Sung Eun Sim, Carl Risinger, Eleni Aklillu, Clinical Pharmacology & Therapeutics	2006	721
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders? Marie Åsberg, Peter Thorén, Lil Träskman, Science PsychopharmacologySerotonin TurnoverMental HealthSocial SciencesSerotonin Depression	1976	679
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Ida Johansson, E Lundqvist, Leif Bertilsson, Proceedings of the National Academy of Sciences	1993	646
Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Inger Johansson, Mikael Oscarson, Qun‐Ying Yue, Molecular Pharmacology	1994	429
Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. Eleni Aklillu, Irene Persson, Leif Bertilsson, Journal of Pharmacology and Experimental Therapeutics	1996	395
Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. Marja‐Liisa Dahl, Inger Johansson, Leif Bertilsson, Journal of Pharmacology and Experimental Therapeutics	1995	313
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Leif Bertilsson, JA Carrillo, M-L Dahl, British Journal of Clinical Pharmacology	1994	306
CSF monoamine metabolites in melancholia Marie Åsberg, Leif Bertilsson, Björn Mårtensson, Acta Psychiatrica Scandinavica NeuropsychologyPsychotropic MedicationPsychopharmacologyNeuropsychiatryMass Fragmentography	1984	286
10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes* Per Dalén, Marja‐Liisa Dahl, Maria Luisa Bernal Ruiz, Clinical Pharmacology & Therapeutics	1998	285
Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine Markus Jerling, Leif Lindström, Ulf Bondesson, Therapeutic Drug Monitoring Drug InteractionsCaffeine TestPsychoactive DrugPsychiatryClozapine Metabolism	1994	279

Page 1